Full Year 2024 Sandoz Group AG Earnings Call Transcript
Key Points
- Sandoz Group AG (SDZNY) achieved over $10 billion in net sales for the first time, driven by strong performance in biosimilars.
- The company reported a core EBITDA margin of 20.1%, reflecting successful margin expansion efforts.
- Sandoz expanded its biosimilars pipeline to 28 assets, maintaining an industry-leading position.
- The company proposed a one-third increase in dividend to $0.60 per share, representing around 25% of core net income.
- Sandoz made significant sustainability progress, reducing greenhouse gases by 12% and providing over 900 million patient treatments globally.
- Currency movements had an adverse 2-percentage-point impact on sales, mainly due to the strength of the US dollar.
- The US generics business faced pricing pressure, contributing to a decline in sales.
- There are ongoing legal challenges, including a preliminary injunction from J&J affecting the launch of a private label product.
- The company anticipates a lower core EBITDA margin in the first half of 2025 due to investments in pipeline and launches.
- Potential US tariffs on goods manufactured in Europe could impact financial performance, with estimated costs ranging from $25 million to $60 million.
Good morning, ladies and gentlemen, and welcome to the Sandoz call today. I will now pass on to Craig Marks, Head of Investor Relations, for his opening remarks.
Thank you. Welcome to the Sandoz Full Year Results Call for 2024. Earlier today, we published our results announcement and an accompanying presentation on our website, which will follow on today's call. You can find these documents at sandoz.com/roinvestors. Joining me on today's call are Richard Saynor, Chief Executive Officer; and Remco Steenbergen, Chief Financial Officer. Please turn to slide 2.
Our results announcement, presentation and discussion include forward-looking statements. Please see our disclaimer on this slide. As a reminder, before the separation from our former parent in October 2023, third-party sales excluded sales to our former parent as this was shown in a separate line item. Post-separation, sales to our formal parts are being reported as third party sales. Please turn to slide 3.
Richard will begin
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
